References
- Cushman D. W., Cheung H. S., Sabo E. F., Ondetti M. A. Design of potent competitive inhibitors of angiotensin converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 1977; 16: 5484–5491
- Vinci J. M., Horwitz D., Zushman R. M., Pisano J. J., Catt K. J., Keiser H. R. The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Hypertension 1979; 1: 416–426
- Iimura O., Shimamoto K., Tanaka S., Hosoda S., Nishitani T., Ando T., Masuda A. The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems. Jap. J. Med. 1986; 25: 34–39
- McCaa R. E., Hall J. E., McCaa C. S. The effects of angiotensin I-converting enzyme inhibitors on arterial blood pressure and urinary sodium excretion. Role of the renal renin-angiotensin and kallikrein-kinin systems. Circ. Res. (Suppl I) 1978; 43: 32–39
- Shimamoto K., Ishida H., Nakahashi Y., Nishitani T., Hosoda S., Yokoyama T., Tanaka S., Iimura O. A very sensitive direct radioimmunoassay system for plasma angiotensin II and its clinical application in various hypertensive diseases. Jpn. Circ. J. 1984; 48: 1228–1235
- Shimamoto K., Ando T., Tanaka S., Iimura O. The determination of kinin and glandular kallikrein in human biological fluids. Allergologie 1986, in press
- Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J. Clin. Endocrinol. 1969; 29: 1349–1355